Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sartorius Ag (SRT3.D.DX)

Sartorius Ag (SRT3.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sartorius Ag Otto-Brenner-Strasse 20 Gottingen NI 37079 DEU

P: +49 5513080

Description:

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Key Statistics

Overview:

Market Capitalization, $K 16,539,767
Shares Outstanding, K 69,038
Annual Sales, $ 3,396 M
Annual Net Income, $ 205,200 K
Last Quarter Sales, $ 793,600 K
Last Quarter Net Income, $ 8,300 K
% of Institutional Shareholders 27.27%

Growth:

1-Year Return -6.37%
3-Year Return -55.32%
5-Year Return 0.00%
5-Year Revenue Growth 16.74%
5-Year Earnings Growth 7.74%
5-Year Dividend Growth 23.07%

Per-Share Information:

Most Recent Earnings 0.34 on 07/19/24
Next Earnings Date N/A
Earnings Per Share ttm 1.13
EPS Growth vs. Prev Qtr -35.85%
EPS Growth vs. Prev Year -0.70%
Annual Dividend Rate, $ 0.74
Annual Dividend Yield 0.30%
Most Recent Dividend 0.740 on 04/02/24
Next Ex-Dividends Date 04/02/24
Dividend Payable Date 04/04/24
Dividend Payout Ratio 65.49%
Most Recent Split 4-1 on 06/13/16

SRT3.D.DX Ratios

Ratio
Price/Earnings ttm 220.89
Price/Earnings forward 50.51
Price/Earnings to Growth 3.22
Return-on-Equity % 7.17%
Return-on-Assets % 1.72%
Profit Margin % 6.04%
Debt/Equity 2.43
Price/Sales 2.58
Price/Cash Flow 10.28
Price/Book 6.37
Book Value/Share 39.21
Interest Coverage 3.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar